Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Scientists from the Max Planck Institute of Biochemistry and the Technical University of Munich have discovered new diagnostic markers of multiple sclerosis (MS) in cerebrospinal fluid (CSF). This was ...

Researchers have identified a set of 22 proteins that distinguish multiple sclerosis from other inflammatory diseases.

The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using plasma samples. The assay requires the SPEAR UltraDet ...

People with persistent cognitive changes after mild COVID had elevated levels of immune activation and immunovascular markers in their cerebrospinal fluid (CSF) 10 months after acute SARS-CoV-2 ...

St. Louis, Nov. 15, 2005 -- A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward ...

CSF-ctDNA was detected in 59% of cases and showed high concordance (84%) with tumor mutations. Lower variant allelic frequency in CSF-ctDNA was associated with significantly worse survival outcomes.

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on ...

In addition to brain imaging, laboratory analysis of cerebrospinal fluid is important for the diagnosis of multiple sclerosis (MS). In this study, proteomic analysis of this fluid has revealed a set ...